Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Histone H3K36M mutation impairs mesenchymal differentiation and drives sarcoma development

ABSTRACT: Histone H3K36M mutation impairs mesenchymal differentiation and drives sarcoma development

PROVIDER: PRJNA266967 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR1648860.fastq.gz	Fastqsanger.gz
	SRR1648861.fastq.gz	Fastqsanger.gz
	SRR1648862.fastq.gz	Fastqsanger.gz
	SRR1648863.fastq.gz	Fastqsanger.gz
	SRR1648864.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Histone H3K36M mutation impairs mesenchymal differentiation and drives sarcoma development [RNA-Seq]

Project description:The goal of this study is to understand the genome-wide alterations in chromatin landscapy induced by a histone mutation (H3.3 K36M) derived from chondroblastomas

2016-09-23 | GSE63194 | GEO

Histone H3K36M mutation impairs mesenchymal differentiation and drives sarcoma development [ChIP-Seq]

Project description:The goal of this study is to understand the genome-wide alterations in chromatin landscapy induced by a histone mutation (H3.3 K36M) derived from chondroblastomas

2016-09-23 | GSE63193 | GEO

Mus musculus

Project description:Histone H3K36M mutation impairs mesenchymal differentiation and drives sarcoma development [RNA_H33_K36M_HMT]

| PRJNA285080 | ENA

Histone H3K36M mutation impairs mesenchymal differentiation and drives sarcoma development

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-09-23 | GSE63195 | GEO

Mus musculus

Project description:Histone H3K36M mutation impairs mesenchymal differentiation and drives sarcoma development [ChIP-Seq]

| PRJNA266971 | ENA

Mus musculus

Project description:Histone H3K36M mutation impairs mesenchymal differentiation and drives sarcoma development [RNA-Seq]

| PRJNA266972 | ENA

Histone H3K36M mutation impairs mesenchymal differentiation and drives sarcoma development [RNA_H33_K36M_HMT]

Project description:The goal of this study is to understand the alterations in transcriptome induced by histone H3K36M mutations

2016-05-13 | GSE69285 | GEO

Exosomal miRNAs from Ewing sarcoma cells and mesenchymal stem cells

Project description:Sarcoma-derived exosomes play an important role in its development and metastasis. Besides the increased secretion of exosomes, the selective packaging of miRNA may contribute to the pathogenesis of sarcoma. Exosomes derived from Ewing sarcoma cells and human mesenchymal stem cells were isolated. Exosomal miRNAs were analyzed by microarray.

2025-03-09 | GSE227018 | GEO

Constitutive Activation of NF-kB Inducing Kinase (NIK) in the Mesenchymal Lineage Drives Spontaneous Soft Tissue Sarcoma

Project description:Aberrant NF-kB signaling fuels tumor growth in multiple human cancer types including both hematologic and solid malignancies. Chronic elevated alternative NF-kB signaling can be modeled in transgenic mice upon activation of a conditional NF-kB-inducing kinase (NIK) allele lacking the regulatory TRAF3 binding domain (NT3). Here, we report that expression of NT3 in the mesenchymal lineage with Osterix (Osx/Sp7)-Cre or Fibroblast Specific Protein (Fsp1)-Cre caused subcutaneous, soft tissue tumors. These tumors displayed significantly shorter latency and a greater multiple incidence rate in Fsp1-Cre;NT3 compared to Osx-Cre;NT3 mice, regardless of sex. Histological assessment revealed poorly differentiated solid tumors with some spindled patterns, as well as robust RelB (Relb) immunostaining, confirming activation of alternative NF-kB. Even though NT3 expression also occurs in the osteolineage in Osx-Cre;NT3 mice, we observed no bony lesions. The staining profiles and pattern of Cre expression in the two lines pointed to a mesenchymal tumor origin. Immunohistochemistry revealed that these tumors stain strongly for SMA (Acta2), although vimentin (Vim) staining was uniform only in Osx-Cre;NT3 tumors. Negative CD45 (Ptprc) and S100 immunostains precluded hematopoietic and melanocytic origins, respectively, while positive staining for CK19 (Krt19), typically associated with epithelia, was found in subpopulations of both tumors. Principal component, differential expression, and gene ontology analyses revealed that NT3 tumors are distinct from normal mesenchymal tissues and are enriched for NF-kB related biological processes. We conclude that constitutive activation of the alternative NF-kB pathway in the mesenchymal linage drives spontaneous sarcoma and provides a novel mouse model for NF-kB related sarcomas.

2020-09-25 | GSE158479 | GEO

Constitutive Activation of NF-kB Inducing Kinase (NIK) in the Mesenchymal Lineage Drives Spontaneous Soft Tissue Sarcoma

Project description:Constitutive Activation of NF-kB Inducing Kinase (NIK) in the Mesenchymal Lineage Drives Spontaneous Soft Tissue Sarcoma

| PRJNA665383 | ENA